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%59.0Age, years 68.99.4 Small vessel disease, % 65.0
Males, % 72.4 Bifurcation (side
branch), %25.0Diabetes Mellitus, % 31.8 Lesion length, mm 163.9
Hypertension, % 79.7 Average vessel
diameter, mmSD
2.70.42History of smoke, % 36.9 Percent diameter
stenosis, %SD
85.99.5LVEF, %SD 53.27.2 Predilatation, % 92.2
Chronic Kidney
disease, %12.3 Pressure, atmospheres 9.4Clinical Presentation:
Stable
coronary artery
disease, %43.3 Duration of balloon
inﬂation, seconds42.511.4NSTEMI, % 50.6 Bailout stenting, % 12.3STEMI, % 4.5 Final percent diameter
stenosis, %9.810.8DES in-stent
restenosis, %28.0 Procedural success, % 97.5BMS in-stent
restenosis, %13.0CONCLUSIONS In this consecutive series of patients, treatment with
a new generation of DCB was found safe and effective in maintaining
good vessel patency at mid-term follow up.
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BACKGROUND Transradial (TR) catheterization has become popular
as a ﬁrst-line approach for coronary angiography due to less bleeding
and access site complications. Recently, the transulnar (TU) approach
has been getting attention as a possible substitute to TR access for
repeat angiographic procedures and in cases of radial artery occlusion.
It also preserves the radial artery for subsequent coronary artery
bypass grafting. In this meta-analysis we attempt to compare safety
and efﬁcacy of TU and TR catheterization.
METHODS Electronic databases were searched for all studies
comparing TU and TR catheterization. A total of 6 studies with 13,285
patients were identiﬁed to be included in this analysis. Outcomes of
interest were major adverse cardiovascular events (MACE), vascular
complications, procedure time, procedure success, and crossover rate.
Odds ratio (OR) or standardized mean difference (SMD) along with
95% conﬁdence intervals (CI) were computed for each outcome. Fixed
and random effects models were used as found appropriate. Sensi-
tivity analysis and bias assessment was done for each outcome.
RESULTS There was no signiﬁcant difference between TR and TU for
MACE [OR 0.83 (CI 0.52 to 1.33), p ¼ 0.43], vascular complications [OR
0.9 (CI 0.61 to 1.32), p ¼ 0.58], crossover rate [OR 1.93 (CI 0.69 to 5.37),
p ¼ 0.21], procedure success [OR 1.17 (CI 0.66 to 2.08), p ¼ 0.61] and
procedure time [SMD -0.14 (CI -0.29 to 0.011), p ¼ 0.07]. Sensitivityanalysis revealed that removal of one study (Geng et al) resulted in a
signiﬁcantly increased summary procedure time in TU catheterization
[SMD -0.21 (CI -0.29 to -0.14), p <0.01]. This study (Geng et al) had
shown a non-signiﬁcant trend towards increase in procedure time in
TR catheterization, which was incongruent with all other studies.
CONCLUSIONS Transulnar catheterization is a safe alternative to
transradial approach and has many potential beneﬁts with similar
rates of procedure success. However, this approach may be associated
with an increased procedure time.
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BACKGROUND Transradial percutaneous coronary intervention (TR-
PCI) is rapidly becoming the gold standard especially in primary percu-
taneous coronary intervention (PCI), where most beneﬁt of the radial
approach can be expected such as reducedmajor bleeding andmortality.
However, transradial access and access-site complications could inﬂu-
ence upper extremity function (UEF). The main objective of this study is
to provide insight in the upper extremity morbidity after TR-PCI. Sec-
ondary objectives are to provide insight in the consequences for func-
tional status, factors inﬂuencing UEF, ﬁnancial costs, and to identify
subjects who might beneﬁt from early referral and treatment.
METHODS This study is a single center prospective cohort study with
a minimum of 490 consecutive patients. All patients will, after base-
line examinations, be treated with the intent of using the radial artery
for PCI access. After the intervention patients will undergo follow-up
after 24 hours, two weeks, one and six months. UEF consist of several
parameters including anatomic integrity, strength, range of motion,
coordination, sensory function and pain. In view of this, we created a
primary endpoint which consists of a combination of parameters,
resulting in a very sensitive binary score for upper extremity
dysfunction (UED). This score was assessed after two weeks as
compared to baseline, using validated examinations and question-
naires. Also, secondary endpoints including spasm, access-site
bleeding and access-site hematoma were assessed.
RESULTS Interim results of 111 patients showed 63 patients (56.8%)
had a positive score for (reversible) UED, of which after two weeks
7 patients (11%) had been referred to a hand rehabilitation specialist
with at the time a Disabilities of Arm, Hand and Shoulder (DASH)
score ranging from 0.9-37.9 points. Long term results need to be
further determined. A multivariate binary logistic regression was
performed to assess the impact of numerous factors on the
endpoint. The strongest predictors were female gender (odds ratio
(OR)¼14.38, 95% conﬁdence interval (CI):2.26-91.47,p¼0.005), pre-
vious percutaneous coronary interventions ((OR)¼7.15, 95%(CI):1.14-
44.9, p¼0.005), and number of skin punctures ((OR)¼8.55,
95%(CI):1.85-39.6, p¼0.006).
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measured with our sensitive score, with 56.8% of the patients having
UED after the procedure. Therefore, special attention during follow-up
regarding the upper extremity is justiﬁed, and should be implemented.
Furthermore, there are indications that certain patients might be at
higher risk and might beneﬁt from slender radial techniques or, in a
speciﬁc minor selection, a switch to transfemoral interventions. Our
UED outcome might be very sensitive, which could be excellent for
assessing the effect of hydrophilic catheter coating and other variables.
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BACKGROUND Transradial approach (TRA) for percutaneous coro-
nary intervention has been shown to decrease access site complica-
tions, bleeding and mortality compared to transfemoral approach
(TFA). However, concerns about higher access site failure rate and
door to balloon time with TRA in ST segment elevation myocardial
infarction (STEMI) remain because data from individual trials has
been conﬂicting. It has led to slow adoption of TRA in STEMI patients
compared to other indications.
METHODS The authors aimed to conduction ﬁrst comprehensive
systemic review and meta-analysis in STEMI patients evaluating
vascular access site failure rate, ﬂuoroscopy time, door to balloon time
and contrast volume used with TRA versus TFA. The PubMed,
CINAHL, clinicaltrials.gov, Embase and CENTRAL databases were
searched for randomized trials comparing TRA versus TFA in STEMI
patients. Trials not reporting data on at least one outcome of interest
were excluded. Random effect models were used to conduct this
meta-analysis with Stata software.
RESULTS Fourteen randomized trials comprising 3758 patients met
inclusion criteria. The access site failure rate was signiﬁcantly higher
TRA compared to TFA (RR 3.30, CI 2.16, 5.03). Random effect inverse
variance weighted prevalence rate meta-analysis showed that access
site failure rate is predicted to be 4% (95% CI 3-6%) with TRA versus 1%
(95%CI 0-1%)with TFA. Door to balloon time (SMD0.30minutes, 95%CI
0.23-0.37 minutes) and ﬂuoroscopy time (SMD 0.14 minutes, 95% CI
0.06-0.23 minutes) were also signiﬁcantly higher in TRA. There was no
difference in the amount of contrastmaterial usedwith TRA versus TFA
(SMD -0.05ml, 95% CI -0.14-0.04ml). Statistical heterogeneity was low
in cross-over rate and contrast volume use, moderate in ﬂuoroscopy
time but high in the door to balloon time comparison.CONCLUSIONS Cross-over rate is signiﬁcantly higher with TRA
compared to TFA in STEMI patients undergoing PCI. It is predicted to
be 3-6% with TRA versus 0-1% with TFA. Fluoroscopy and door to
balloon times are also modestly yet signiﬁcantly higher with TRA but
there is no difference in terms of contrast volume use. More research
is needed to study outcomes in STEMI patients who require cross-over
to alternate access site.
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BACKGROUND Radial approach is associated with a signiﬁcantly
reduced incidence of vascular complications and bleedings following
coronary angiography and percutaneous coronary interventions as
compared to femoral approach. Several vascular closure devices
(VCD) designed for femoral hemostasis have been proposed as an
alternative strategy in order to reduce access-related bleedings.
However, evidence about their efﬁcacy as compared to radial
approach is lacking.
METHODS In order to systematically review studies comparing radial
approach with femoral approach and achievement of hemostasis by
VCD, we conducted a search on major electronic databases entering
the following key words: “radial”, “vascular access”, “femoral”,
“coronary”, “closure devices”. Studies reporting outcomes on access-
site complications and/or major bleedings were included in the anal-
ysis. Data were extracted by two independent reviewers; odds ratio
(OR) and 95% conﬁdence interval (CI) were calculated by random-
effects model and were used as summary statistics. Review Manager
5.3 software was used for the analysis.
RESULTS Four randomized and seven non-randomized studies were
included in the meta-analysis. Outcome data about access-site com-
plications were available for 132,729 patients treated by radial
approach and 461,892 patients treated by femoral approach þ VCD,
whereas outcome data about major bleedings were available for
81,892 patients treated by radial approach and 79,884 patients treated
by femoral approach þ VCD, respectively. Both access-site complica-
tions (OR 0.29, 95% CI 0.22-0.39) and major bleedings (OR 0.43, 95%
CI 0.36-0.51) were signiﬁcantly reduced with radial approach as
compared to femoral approach þ VCD (Figure).
